
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Détail de l'auteur
Auteur P. F. A. DE NIJS |
Documents disponibles écrits par cet auteur (3)



ASD Symptom Severity in Adolescence of Individuals Diagnosed with PDD-NOS in Childhood: Stability and the Relation with Psychiatric Comorbidity and Societal Participation / A. LOUWERSE in Journal of Autism and Developmental Disorders, 45-12 (December 2015)
![]()
[article]
Titre : ASD Symptom Severity in Adolescence of Individuals Diagnosed with PDD-NOS in Childhood: Stability and the Relation with Psychiatric Comorbidity and Societal Participation Type de document : Texte imprimé et/ou numérique Auteurs : A. LOUWERSE, Auteur ; M. L. J. M. EUSSEN, Auteur ; J. VAN DER ENDE, Auteur ; P. F. A. DE NIJS, Auteur ; A. R. VAN GOOL, Auteur ; Linda P. DEKKER, Auteur ; C. VERHEIJ, Auteur ; F. VERHEIJ, Auteur ; F. C. VERHULST, Auteur ; K. GREAVES-LORD, Auteur Année de publication : 2015 Article en page(s) : p.3908-3918 Langues : Anglais (eng) Mots-clés : Autism spectrum disorders (ASD) Pervasive developmental disorder-not otherwise specified (PDD-NOS) Comorbid psychiatric disorders Follow-up Autism Diagnostic Observation Schedule (ADOS-2) Symptom severity Societal functioning Index. décimale : PER Périodiques Résumé : The current 7-year follow-up study investigated: (1) the stability of ASD severity, and (2) associations of ASD severity in adolescence with (a) childhood and concurrent psychiatric comorbidity, and (b) concurrent societal functioning. The Autism Diagnostic Observation Schedule (ADOS) and the Diagnostic Interview Schedule for Children were administered in childhood (ages 6–12) and in adolescence (ages 12–20) to 72 individuals with a pervasive developmental disorder-not otherwise specified (PDD-NOS). ADOS calibrated severity scores showed a large stability (r = .51). Psychiatric comorbidity in childhood and adolescence were not associated with ASD severity in adolescence. Mental health care use (87 %) and special education needs were high (71 %). Reevaluation of ASD severity and psychiatric comorbidity later in life seem useful when PDD-NOS is diagnosed in childhood. En ligne : http://dx.doi.org/10.1007/s10803-015-2595-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=273
in Journal of Autism and Developmental Disorders > 45-12 (December 2015) . - p.3908-3918[article] ASD Symptom Severity in Adolescence of Individuals Diagnosed with PDD-NOS in Childhood: Stability and the Relation with Psychiatric Comorbidity and Societal Participation [Texte imprimé et/ou numérique] / A. LOUWERSE, Auteur ; M. L. J. M. EUSSEN, Auteur ; J. VAN DER ENDE, Auteur ; P. F. A. DE NIJS, Auteur ; A. R. VAN GOOL, Auteur ; Linda P. DEKKER, Auteur ; C. VERHEIJ, Auteur ; F. VERHEIJ, Auteur ; F. C. VERHULST, Auteur ; K. GREAVES-LORD, Auteur . - 2015 . - p.3908-3918.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 45-12 (December 2015) . - p.3908-3918
Mots-clés : Autism spectrum disorders (ASD) Pervasive developmental disorder-not otherwise specified (PDD-NOS) Comorbid psychiatric disorders Follow-up Autism Diagnostic Observation Schedule (ADOS-2) Symptom severity Societal functioning Index. décimale : PER Périodiques Résumé : The current 7-year follow-up study investigated: (1) the stability of ASD severity, and (2) associations of ASD severity in adolescence with (a) childhood and concurrent psychiatric comorbidity, and (b) concurrent societal functioning. The Autism Diagnostic Observation Schedule (ADOS) and the Diagnostic Interview Schedule for Children were administered in childhood (ages 6–12) and in adolescence (ages 12–20) to 72 individuals with a pervasive developmental disorder-not otherwise specified (PDD-NOS). ADOS calibrated severity scores showed a large stability (r = .51). Psychiatric comorbidity in childhood and adolescence were not associated with ASD severity in adolescence. Mental health care use (87 %) and special education needs were high (71 %). Reevaluation of ASD severity and psychiatric comorbidity later in life seem useful when PDD-NOS is diagnosed in childhood. En ligne : http://dx.doi.org/10.1007/s10803-015-2595-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=273 Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1) / S. EIJK in Journal of Autism and Developmental Disorders, 48-7 (July 2018)
![]()
[article]
Titre : Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1) Type de document : Texte imprimé et/ou numérique Auteurs : S. EIJK, Auteur ; S. E. MOUS, Auteur ; G. C. DIELEMAN, Auteur ; Bram DIERCKX, Auteur ; A. B. RIETMAN, Auteur ; P. F. A. DE NIJS, Auteur ; L. W. TEN HOOPEN, Auteur ; R. VAN MINKELEN, Auteur ; Y. ELGERSMA, Auteur ; Coriene E. CATSMAN-BERREVOETS, Auteur ; R. OOSTENBRINK, Auteur ; J. S. LEGERSTEE, Auteur Article en page(s) : p.2278-2285 Langues : Anglais (eng) Mots-clés : Autism diagnostic observation schedule Autism spectrum disorder Autistic traits Neurofibromatosis type 1 Prevalence Social responsiveness scale Index. décimale : PER Périodiques Résumé : In a non-selected sample of children with Neurofibromatosis type 1 (NF1) the prevalence rate of autism spectrum disorder (ASD) and predictive value of an observational (ADOS)-and questionnaire-based screening instrument were assessed. Complete data was available for 128 children. The prevalence rate for clinical ASD was 10.9%, which is clearly higher than in the general population. This prevalence rate is presumably more accurate than in previous studies that examined children with NF1 with an ASD presumption or solely based on screening instruments. The combined observational- and screening based classifications demonstrated the highest positive predictive value for DSM-IV diagnosis, highlighting the importance of using both instruments in children with NF1. En ligne : http://dx.doi.org/10.1007/s10803-018-3478-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=367
in Journal of Autism and Developmental Disorders > 48-7 (July 2018) . - p.2278-2285[article] Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1) [Texte imprimé et/ou numérique] / S. EIJK, Auteur ; S. E. MOUS, Auteur ; G. C. DIELEMAN, Auteur ; Bram DIERCKX, Auteur ; A. B. RIETMAN, Auteur ; P. F. A. DE NIJS, Auteur ; L. W. TEN HOOPEN, Auteur ; R. VAN MINKELEN, Auteur ; Y. ELGERSMA, Auteur ; Coriene E. CATSMAN-BERREVOETS, Auteur ; R. OOSTENBRINK, Auteur ; J. S. LEGERSTEE, Auteur . - p.2278-2285.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 48-7 (July 2018) . - p.2278-2285
Mots-clés : Autism diagnostic observation schedule Autism spectrum disorder Autistic traits Neurofibromatosis type 1 Prevalence Social responsiveness scale Index. décimale : PER Périodiques Résumé : In a non-selected sample of children with Neurofibromatosis type 1 (NF1) the prevalence rate of autism spectrum disorder (ASD) and predictive value of an observational (ADOS)-and questionnaire-based screening instrument were assessed. Complete data was available for 128 children. The prevalence rate for clinical ASD was 10.9%, which is clearly higher than in the general population. This prevalence rate is presumably more accurate than in previous studies that examined children with NF1 with an ASD presumption or solely based on screening instruments. The combined observational- and screening based classifications demonstrated the highest positive predictive value for DSM-IV diagnosis, highlighting the importance of using both instruments in children with NF1. En ligne : http://dx.doi.org/10.1007/s10803-018-3478-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=367 Motor problems in children with neurofibromatosis type 1 / A. B. RIETMAN in Journal of Neurodevelopmental Disorders, 9-1 (December 2017)
![]()
[article]
Titre : Motor problems in children with neurofibromatosis type 1 Type de document : Texte imprimé et/ou numérique Auteurs : A. B. RIETMAN, Auteur ; R. OOSTENBRINK, Auteur ; S. BONGERS, Auteur ; E. GAUKEMA, Auteur ; S. VAN ABEELEN, Auteur ; J. G. HENDRIKSEN, Auteur ; C. W. N. LOOMAN, Auteur ; P. F. A. DE NIJS, Auteur ; M. C. DE WIT, Auteur Article en page(s) : p.19 Langues : Anglais (eng) Mots-clés : Dcd Emotional and behavioural problems Intelligence Motor problems Neurofibromatosis type 1 Index. décimale : PER Périodiques Résumé : BACKGROUND: Children with the neurogenetic disorder neurofibromatosis type 1 (NF1) often have problems with learning and behaviour. In both parent reports and neuropsychological assessment, motor problems are reported in approximately one third to one half of the children with NF1. Studies using broad motor performance test batteries with relatively large groups of children with NF1 are limited. The aim of this cross-sectional observational study was to describe the severity of motor problems in children with NF1 and to explore the predictive value of demographics, intelligence, and behavioural problems. METHODS: From 2002 to 2014, 69 children with NF1, aged 4 to 16 years (age = 9.5 +/- 2.8 years; 29 girls) had a motor, psychological, and neurological evaluation in an NF1 expertise centre. Data were collected about (1) motor performance (M-ABC: Movement Assessment Battery for Children), (2) intelligence, and (3) emotional and behavioural problems as rated by parents. RESULTS: Sixty-one percent of these children scored within the clinical range of the M-ABC. In ordinal logistic regression analyses, motor problems were associated with symptoms of attention-deficit/hyperactivity disorder (ADHD), symptoms of autism spectrum disorder (ASD), and externalising behavioural problems. Motor outcome was not predicted by age, intelligence, scoliosis, hypotonia, nor hypermobility. CONCLUSIONS: Motor problems are among the most common comorbid developmental problems in children with NF1, and these problems do not diminish with age. Because of their impact on daily functioning, motor problems need to be specifically addressed in diagnosis, follow-up, and treatment of NF1. En ligne : http://dx.doi.org/10.1186/s11689-017-9198-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=350
in Journal of Neurodevelopmental Disorders > 9-1 (December 2017) . - p.19[article] Motor problems in children with neurofibromatosis type 1 [Texte imprimé et/ou numérique] / A. B. RIETMAN, Auteur ; R. OOSTENBRINK, Auteur ; S. BONGERS, Auteur ; E. GAUKEMA, Auteur ; S. VAN ABEELEN, Auteur ; J. G. HENDRIKSEN, Auteur ; C. W. N. LOOMAN, Auteur ; P. F. A. DE NIJS, Auteur ; M. C. DE WIT, Auteur . - p.19.
Langues : Anglais (eng)
in Journal of Neurodevelopmental Disorders > 9-1 (December 2017) . - p.19
Mots-clés : Dcd Emotional and behavioural problems Intelligence Motor problems Neurofibromatosis type 1 Index. décimale : PER Périodiques Résumé : BACKGROUND: Children with the neurogenetic disorder neurofibromatosis type 1 (NF1) often have problems with learning and behaviour. In both parent reports and neuropsychological assessment, motor problems are reported in approximately one third to one half of the children with NF1. Studies using broad motor performance test batteries with relatively large groups of children with NF1 are limited. The aim of this cross-sectional observational study was to describe the severity of motor problems in children with NF1 and to explore the predictive value of demographics, intelligence, and behavioural problems. METHODS: From 2002 to 2014, 69 children with NF1, aged 4 to 16 years (age = 9.5 +/- 2.8 years; 29 girls) had a motor, psychological, and neurological evaluation in an NF1 expertise centre. Data were collected about (1) motor performance (M-ABC: Movement Assessment Battery for Children), (2) intelligence, and (3) emotional and behavioural problems as rated by parents. RESULTS: Sixty-one percent of these children scored within the clinical range of the M-ABC. In ordinal logistic regression analyses, motor problems were associated with symptoms of attention-deficit/hyperactivity disorder (ADHD), symptoms of autism spectrum disorder (ASD), and externalising behavioural problems. Motor outcome was not predicted by age, intelligence, scoliosis, hypotonia, nor hypermobility. CONCLUSIONS: Motor problems are among the most common comorbid developmental problems in children with NF1, and these problems do not diminish with age. Because of their impact on daily functioning, motor problems need to be specifically addressed in diagnosis, follow-up, and treatment of NF1. En ligne : http://dx.doi.org/10.1186/s11689-017-9198-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=350